|
Dynavax & AstraZeneca Alter Agreement for Asthma Product
Yahoo News As per the agreement, AstraZeneca will now provide full funding while Dynavax will conduct a phase IIa safety and efficacy trial on pipeline candidate AZD1419 in asthma patients. Dynavax plans to initiate the study in the first half of 2015. The … |
View full post on asthma – Google News